ADIPOGEN Trademark

Trademark Overview


On Friday, December 19, 2008, a trademark application was filed for ADIPOGEN with the United States Patent and Trademark Office. The USPTO has given the ADIPOGEN trademark a serial number of 77636854. The federal status of this trademark filing is REGISTERED AND RENEWED as of Tuesday, May 31, 2022. This trademark is owned by AdipoGen Incorporation. The ADIPOGEN trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Biological preparations for medical purposes; Chemical reagents for medical or veterinary purposes; Diagnostic agents, preparations and substances for medical purposes; Diagnostic kits consisting primarily of polyclonal and monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic preparations for medical purposes; Diagnostic reagents for medicinal use; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Medical diagnostic reagents; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of obesity and diabetes and inflammatory disorders, for use in angiogenesis, dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gas...

Assays for research purposes; Biochemical proteins, enzymes and antibodies for scientific and medical research; Biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; Biochemicals, namely, polypeptides for in vitro research use; Biochemicals, namely, polyclonal and monoclonal antibodies for in vitro scientific or research use; Biomedical compounds, namely, peptide substrates used in analyzing and detecting enzymes and proteins for laboratory or research use; Chemicals for use in the purification of proteins for in vitro use; Diagnostic kits for research and in vitro use consisting primarily of polyclonal and monoclonal antibodies, buffers [, and reagents ] to monitor proteins and reagents; Diagnostics, namely, diagnostic preparations and reagents other than for medical or veterinary purposes; Diagnostic preparations and reagents for scientific or research use; Diagnostic preparations and reagents for clinical or medical lab...
adipogen

General Information


Serial Number77636854
Word MarkADIPOGEN
Filing DateFriday, December 19, 2008
Status800 - REGISTERED AND RENEWED
Status DateTuesday, May 31, 2022
Registration Number4146965
Registration DateTuesday, May 22, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 14, 2009

Trademark Statements


Goods and ServicesBiological preparations for medical purposes; Chemical reagents for medical or veterinary purposes; Diagnostic agents, preparations and substances for medical purposes; Diagnostic kits consisting primarily of polyclonal and monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic preparations for medical purposes; Diagnostic reagents for medicinal use; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Medical diagnostic reagents; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of obesity and diabetes and inflammatory disorders, for use in angiogenesis, dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders [ ; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and natural medicinal extracts derived from animal, plant and microorganism sources for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, obesity and diabetes, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Reagents and media for medical and veterinary diagnostic purposes ]
Pseudo MarkADIPO GEN
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesAssays for research purposes; Biochemical proteins, enzymes and antibodies for scientific and medical research; Biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; Biochemicals, namely, polypeptides for in vitro research use; Biochemicals, namely, polyclonal and monoclonal antibodies for in vitro scientific or research use; Biomedical compounds, namely, peptide substrates used in analyzing and detecting enzymes and proteins for laboratory or research use; Chemicals for use in the purification of proteins for in vitro use; Diagnostic kits for research and in vitro use consisting primarily of polyclonal and monoclonal antibodies, buffers [, and reagents ] to monitor proteins and reagents; Diagnostics, namely, diagnostic preparations and reagents other than for medical or veterinary purposes; Diagnostic preparations and reagents for scientific or research use; Diagnostic preparations and reagents for clinical or medical laboratory use; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; Protein arrays and nucleotide arrays for scientific and medical research; Reagent for chemical analyses; Reagents for scientific or medical research use; Reagents for use in scientific apparatus for chemical or biological analysis; Stem cells and stem cell reagents for research purposes; Testing kits containing peptide substrates used in analyzing and detecting proteins, enzymes and receptors for laboratory or research use; Testing kits containing peptide substrates used in analyzing and detecting proteins, enzymes and receptors for clinical or medical laboratory use

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateTuesday, December 23, 2008
Primary Code001
First Use Anywhere DateSunday, November 1, 2009
First Use In Commerce DateSunday, November 1, 2009

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 7, 2009
Primary Code005
First Use Anywhere DateSunday, November 1, 2009
First Use In Commerce DateSunday, November 1, 2009

Trademark Owner History


Party NameADIPOGEN LIFE SCIENCES, INC.
Party Type32 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressSAN DIEGO, CA 92121

Party NameADIPOGEN INTERNATIONAL, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressSAN DIEGO, CA 92121

Party NameAdipoGen Incorporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressYeonsu-gu Incheon 406-840
KP

Party NameAdipoGen Incorporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressYeonsu-gu Incheon 406-840
KP

Party NameAdipoGen Incorporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeoul 136-701
KR

Trademark Events


Event DateEvent Description
Tuesday, May 31, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Tuesday, May 31, 2022REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Tuesday, May 31, 2022REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, May 26, 2022TEAS SECTION 8 & 9 RECEIVED
Thursday, September 9, 2021OFFICE ACTION ISSUED POU1
Thursday, September 9, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, August 24, 2021TEAS SECTION 8 & 9 RECEIVED
Saturday, May 22, 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, May 24, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, May 24, 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, May 24, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, May 10, 2018TEAS SECTION 8 & 15 RECEIVED
Wednesday, August 9, 2017AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, May 22, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, February 12, 2014AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, May 22, 2012REGISTERED-PRINCIPAL REGISTER
Tuesday, April 17, 2012NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, April 16, 2012LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, April 13, 2012ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, March 30, 2012STATEMENT OF USE PROCESSING COMPLETE
Wednesday, March 28, 2012USE AMENDMENT FILED
Wednesday, March 28, 2012TEAS STATEMENT OF USE RECEIVED
Thursday, October 20, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 19, 2011SOU EXTENSION 4 GRANTED
Wednesday, October 5, 2011SOU EXTENSION 4 FILED
Wednesday, October 5, 2011TEAS EXTENSION RECEIVED
Saturday, April 2, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 1, 2011SOU EXTENSION 3 GRANTED
Monday, March 28, 2011SOU EXTENSION 3 FILED
Monday, March 28, 2011TEAS EXTENSION RECEIVED
Wednesday, October 13, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 13, 2010ASSIGNED TO EXAMINER
Tuesday, October 12, 2010SOU EXTENSION 2 GRANTED
Friday, September 24, 2010SOU EXTENSION 2 FILED
Tuesday, October 12, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, September 24, 2010TEAS EXTENSION RECEIVED
Wednesday, April 7, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 5, 2010SOU EXTENSION 1 GRANTED
Monday, April 5, 2010SOU EXTENSION 1 FILED
Monday, April 5, 2010TEAS EXTENSION RECEIVED
Friday, December 4, 2009APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, December 4, 2009TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, October 9, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 6, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 14, 2009PUBLISHED FOR OPPOSITION
Wednesday, June 24, 2009NOTICE OF PUBLICATION
Tuesday, June 9, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, June 9, 2009ASSIGNED TO LIE
Sunday, June 7, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, June 7, 2009EXAMINER'S AMENDMENT ENTERED
Sunday, June 7, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sunday, June 7, 2009EXAMINERS AMENDMENT E-MAILED
Sunday, June 7, 2009EXAMINERS AMENDMENT -WRITTEN
Thursday, May 7, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 7, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 7, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, March 22, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, March 22, 2009NON-FINAL ACTION E-MAILED
Sunday, March 22, 2009NON-FINAL ACTION WRITTEN
Saturday, March 14, 2009ASSIGNED TO EXAMINER
Wednesday, December 24, 2008NOTICE OF PSEUDO MARK MAILED
Tuesday, December 23, 2008NEW APPLICATION ENTERED IN TRAM